PUBLICATION
Novel truncation mutations in MYRF cause autosomal dominant high hyperopia mapped to 11p12-q13.3
- Authors
- Xiao, X., Sun, W., Ouyang, J., Li, S., Jia, X., Tan, Z., Hejtmancik, J.F., Zhang, Q.
- ID
- ZDB-PUB-190608-8
- Date
- 2019
- Source
- Human genetics 138(10): 1077-1090 (Journal)
- Registered Authors
- Hejtmancik, J. Fielding
- Keywords
- none
- MeSH Terms
-
- Animals
- Chromosome Mapping
- Chromosomes, Human, Pair 11*
- DNA Mutational Analysis
- Eye Diseases, Hereditary/diagnosis
- Eye Diseases, Hereditary/genetics*
- Female
- Fluorescein Angiography
- Gene Knockout Techniques
- Genes, Dominant*
- Genetic Association Studies*
- Genetic Loci
- Genetic Predisposition to Disease*
- Humans
- Hyperopia/diagnosis
- Hyperopia/genetics*
- Lod Score
- Male
- Membrane Proteins/genetics*
- Mutation*
- Pedigree
- Phenotype
- Transcription Factors/genetics*
- Zebrafish
- PubMed
- 31172260 Full text @ Hum. Genet.
Citation
Xiao, X., Sun, W., Ouyang, J., Li, S., Jia, X., Tan, Z., Hejtmancik, J.F., Zhang, Q. (2019) Novel truncation mutations in MYRF cause autosomal dominant high hyperopia mapped to 11p12-q13.3. Human genetics. 138(10):1077-1090.
Abstract
High hyperopia is a common and severe form of refractive error. Genetic factors play important roles in the development of high hyperopia but the exact gene responsible for this condition is mostly unknown. We identified a large Chinese family with autosomal dominant high hyperopia. A genome-wide linkage scan mapped the high hyperopia to chromosome 11p12-q13.3, with maximum log of the odds scores of 4.68 at theta = 0 for D11S987. Parallel whole-exome sequencing detected a novel c.3377delG (p.Gly1126Valfs*31) heterozygous mutation in the MYRF gene within the linkage interval. Whole-exome sequencing in other 121 probands with high hyperopia identified additional novel mutations in MYRF within two other families: a de novo c.3274_3275delAG (p.Leu1093Profs*22) heterozygous mutation and a c.3194+2T>C heterozygous mutation. All three mutations are located in the C-terminal region of MYRF and are predicted to result in truncation of that portion. Two patients from two of the three families developed angle-closure glaucoma. These three mutations were present in neither the ExAC database nor our in-house whole-exome sequencing data from 3280 individuals. No other truncation mutations in MYRF were detected in the 3280 individuals. Knockdown of myrf resulted in small eye size in zebrafish. These evidence all support that truncation mutations in the C-terminal region of MYRF are responsible for autosomal dominant high hyperopia in these families. Our results may provide useful clues for further understanding the functional role of the C-terminal region of this critical myelin regulatory factor, as well as the molecular pathogenesis of high hyperopia and its associated angle-closure glaucoma.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping